Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Concord Biotech Ltd Financial Statements & Historical Data

Updated NSE: CONCORDBIOBSE: 543960
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 5 October 2026, 10:55 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,356₹ per share
Reported P/E49.8Times
Book value per share193₹ per share
Reported ROCE17.4 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 5 October 2026, 10:55 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap14,175 Cr.
Current Price1,356
High / Low1,648/987
Stock P/E49.8
Book Value193
Dividend Yield0.56 %
ROCE17.4 %
ROE12.6 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Concord Biotech Ltd 14,175 Cr. 1,356 1,648/98749.8 1930.56 %17.4 %12.6 % 1.00
Marksans Pharma Ltd 13,976 Cr. 308 351/15527.0 66.70.28 %18.8 %15.2 % 1.00
Astrazeneca Pharma India Ltd 14,795 Cr. 5,918 9,850/5,80285.3 3490.61 %29.3 %23.3 % 2.00
Jubilant Pharmova Ltd 15,525 Cr. 975 1,185/78440.0 4450.51 %8.99 %6.53 % 1.00
Natco Pharma Ltd 15,615 Cr. 796 1,217/78613.8 4700.62 %17.4 %17.1 % 2.00
Industry Average17,397.24 Cr1,233.9354.22211.240.39%26.16%16.59%6.06

All Competitor Stocks of Concord Biotech Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 195262241319216310244430204247278326261
Expenses 123143135185135174146239143157176204173
Operating Profit 721191061348113798190619110212287
OPM % 37%45%44%42%38%44%40%44%30%37%37%38%33%
Other Income 788111010159141371613
Interest 1100000000000
Depreciation 13131414131313151818191918
Profit before tax 65113100131781339918557869011882
Tax % 25%25%26%26%25%26%25%23%26%26%25%24%26%
Net Profit 488475975899741424363689061
EPS in Rs 4.638.087.139.295.579.437.0813.574.076.016.488.605.85

Last Updated: September 29, 2026, 7:38 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 10:18 pm

MetricMar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 2392763404365126177138531,0171,2001,0551,112
Expenses 133145212256308289439509585693678709
Operating Profit 105131127180205328274344432507377402
OPM % 44%48%37%41%40%53%38%40%42%42%36%36%
Other Income 11836173114233534444949
Interest 101111653110
Depreciation 101018192128505454547475
Profit before tax 106129144178213313241320409496351376
Tax % 34%33%30%33%21%25%26%26%26%25%25%
Net Profit 7087100118169235179238305373263282
EPS in Rs 76.3294.78105.66124.48177.65247.44187.7622.7629.1335.6525.1726.94
Dividend Payout % 22%25%0%21%22%0%3%30%30%25%30%

YoY Net Profit Growth

Year2015-20162018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)24.29%18.00%43.22%39.05%-23.83%32.96%28.15%22.30%-29.49%
Change in YoY Net Profit Growth (%)0.00%-6.29%25.22%-4.17%-62.88%56.79%-4.81%-5.86%-51.79%

Concord Biotech Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2025-2026.

Growth

Last Updated: September 5, 2025, 3:01 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 12, 2026, 4:30 am

MonthMar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 99101010101010101010
Reserves 2683295856737619901,0981,2821,5151,8022,009
Borrowings 3536229528962321031
Other Liabilities 5574697111894144191164219216
Total Liabilities 3674486857639411,1831,3131,5151,6992,0342,237
Fixed Assets 104110189230240546573593575795786
CWIP 197031914118741732115179
Investments 424315122919914274138244335488
Other Assets 202225343285361477592611668854883
Total Assets 3674486857639411,1831,3131,5151,6992,0342,237
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 79155167207246265245264
Cash from Investing Activity + -42-114-195-112-158-155-160-142
Cash from Financing Activity + -37-4331-100-85-99-99-115
Net Cash Flow 0-13-4312-147
Free Cash Flow 79-1-3752101180134169
CFO/OP 101%100%74%98%92%85%70%96%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash FlowN/AN/A79.00N/A-1.00-37.0052.00101.00180.00134.00169.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 236133131105119117125159
Inventory Days 381310312503434430331286
Days Payable 210112201152185190150135
Cash Conversion Cycle 407331242456368357306310
Working Capital Days 275186159177163153166193
ROCE %27%25%32%21%26%28%28%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 44.08%44.08%44.08%44.08%44.08%44.08%44.08%44.08%44.08%44.08%44.08%44.08%
FIIs 7.30%7.00%6.49%7.11%8.10%8.33%9.35%9.10%8.03%7.58%7.79%7.53%
DIIs 8.12%8.40%8.41%10.35%9.89%9.65%9.16%8.85%9.55%9.58%9.22%9.37%
Public 40.50%40.52%41.03%38.46%37.95%37.93%37.41%37.94%38.32%38.75%38.90%39.04%
No. of Shareholders 1,00,92787,48683,29680,73784,29882,00481,21982,04582,65081,81582,24983,325
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
DSP Small Cap Fund 1,331,725 0.85 152.08920,4272026-01-25 08:13:2644.69%
DSP Healthcare Fund 496,688 1.81 56.72489,7742026-03-11 07:16:211.41%
Edelweiss Small Cap Fund 462,606 0.89 52.83280,0092026-06-11 02:48:5165.21%
Invesco India Flexi Cap Fund 178,114 0.42 20.34N/AN/AN/A
Nippon India Pharma Fund 111,738 0.15 12.76N/AN/AN/A
Invesco India Aggressive Hybrid Fund 42,148 0.63 4.81N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22
FaceValue 1.001.001.0010.00
Basic EPS (Rs.) 35.5229.4522.9516.72
Diluted EPS (Rs.) 35.5229.4522.9516.72
Cash EPS (Rs.) 40.8534.2527.93240.38
Book Value[Excl.RevalReserv]/Share (Rs.) 173.27145.93123.311159.99
Book Value[Incl.RevalReserv]/Share (Rs.) 173.27145.93123.311159.99
Revenue From Operations / Share (Rs.) 114.7197.2181.55749.62
PBDIT / Share (Rs.) 52.6544.4836.19311.96
PBIT / Share (Rs.) 47.4539.3631.02259.33
PBT / Share (Rs.) 47.4039.1130.59253.57
Net Profit / Share (Rs.) 35.6529.1322.76187.76
NP After MI And SOA / Share (Rs.) 35.5229.4522.95183.93
PBDIT Margin (%) 45.8945.7544.3741.61
PBIT Margin (%) 41.3640.4838.0434.59
PBT Margin (%) 41.3140.2337.5133.82
Net Profit Margin (%) 31.0729.9627.9125.04
NP After MI And SOA Margin (%) 30.9630.2928.1424.53
Return on Networth / Equity (%) 20.5020.1818.6115.85
Return on Capital Employeed (%) 26.8226.4124.5421.30
Return On Assets (%) 18.2618.1115.8513.32
Long Term Debt / Equity (X) 0.000.000.000.02
Total Debt / Equity (X) 0.000.000.020.05
Asset Turnover Ratio (%) 0.640.630.600.00
Current Ratio (X) 6.176.303.794.08
Quick Ratio (X) 4.874.842.692.82
Inventory Turnover Ratio (X) 5.360.870.820.00
Dividend Payout Ratio (NP) (%) 24.6323.1922.3140.31
Dividend Payout Ratio (CP) (%) 21.4819.7518.2131.34
Earning Retention Ratio (%) 75.3776.8177.6959.69
Cash Earning Retention Ratio (%) 78.5280.2581.7968.66
Interest Coverage Ratio (X) 1040.58182.3583.9454.11
Interest Coverage Ratio (Post Tax) (X) 705.64120.4153.8033.56
Enterprise Value (Cr.) 17536.5015881.240.000.00
EV / Net Operating Revenue (X) 14.6115.620.000.00
EV / EBITDA (X) 31.8434.130.000.00
MarketCap / Net Operating Revenue (X) 14.6115.660.000.00
Retention Ratios (%) 75.3676.8077.6859.68
Price / BV (X) 9.6710.430.000.00
Price / Net Operating Revenue (X) 14.6115.660.000.00
EarningsYield 0.020.010.000.00
Advertisements
Explore Industry-wise Company financial data